DC
NVO

Davenport & Co’s Novo Nordisk NVO Stock Holding History

Davenport & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Sell
71,408
-13,376
-16% -$575K 0.02% 451
2026
Q1 		$3.12M Sell
84,784
-2,122,035
-96% -$101M 0.02% 436
2025
Q4 		$113M Sell
2,206,819
-435,679
-16% -$22.3M 0.6% 51
2025
Q3 		$147M Buy
2,642,498
+935,468
+55% +$54.8M 0.78% 29
2025
Q2 		$118M Buy
1,707,030
+11,508
+0.7% +$783K 0.64% 47
2025
Q1 		$118M Buy
1,695,522
+642,810
+61% +$53.1M 0.68% 45
2024
Q4 		$90.5M Buy
1,052,712
+451,641
+75% +$48.8M 0.51% 68
2024
Q3 		$71.8M Sell
601,071
-2,370
-0.4% -$316K 0.41% 90
2024
Q2 		$86.1M Sell
603,441
-1,031
-0.2% -$137K 0.52% 68
2024
Q1 		$77.3M Sell
604,472
-302
-0% -$36K 0.47% 77
2023
Q4 		$62.4M Buy
604,774
+1,917
+0.3% +$190K 0.42% 85
2023
Q3 		$54.8M Buy
602,857
+2,395
+0.4% +$211K 0.41% 82
2023
Q2 		$48.2M Sell
600,462
-193,496
-24% -$15.8M 0.35% 92
2023
Q1 		$62.9M Sell
793,958
-9,532
-1% -$676K 0.49% 71
2022
Q4 		$54.3M Buy
803,490
+782,794
+3,782% +$45.9M 0.44% 77
2022
Q3 		$1.03M Buy
20,696
+8,726
+73% +$467K 0.01% 489
2022
Q2 		$667K Buy
11,970
+630
+6% +$35K 0.01% 598
2022
Q1 		$630K Sell
11,340
-540
-5% -$27.7K ﹤0.01% 674
2021
Q4 		$665K Sell
11,880
-950
-7% -$51.5K ﹤0.01% 682
2021
Q3 		$616K Buy
12,830
+2,176
+20% +$105K ﹤0.01% 670
2021
Q2 		$446K Buy
10,654
+84
+0.8% +$3.26K ﹤0.01% 678
2021
Q1 		$356K Hold
10,570
– – ﹤0.01% 611
2020
Q4 		$369K Sell
10,570
-240
-2% -$8.29K ﹤0.01% 593
2020
Q3 		$375K Hold
10,810
– – ﹤0.01% 526
2020
Q2 		$354K Hold
10,810
– – ﹤0.01% 519
2020
Q1 		$325K Hold
10,810
– – ﹤0.01% 490
2019
Q4 		$313K Buy
10,810
+258
+2% +$7.14K ﹤0.01% 577
2019
Q3 		$269K Buy
10,552
+192
+2% +$4.86K ﹤0.01% 586
2019
Q2 		$264K Sell
10,360
-1,000
-9% -$24.7K ﹤0.01% 593
2019
Q1 		$297K Sell
11,360
-350
-3% -$8.6K ﹤0.01% 543
2018
Q4 		$270K Buy
11,710
+640
+6% +$14.2K ﹤0.01% 539
2018
Q3 		$261K Sell
11,070
-400
-3% -$9.76K ﹤0.01% 581
2018
Q2 		$264K Hold
11,470
– – ﹤0.01% 579
2018
Q1 		$282K Sell
11,470
-750
-6% -$19.7K ﹤0.01% 570
2017
Q4 		$328K Sell
12,220
-2,300
-16% -$58.5K ﹤0.01% 531
2017
Q3 		$350K Sell
14,520
-500
-3% -$11.3K ﹤0.01% 510
2017
Q2 		$322K Buy
15,020
+1,750
+13% +$35.3K ﹤0.01% 519
2017
Q1 		$238K Sell
13,270
-200
-1% -$3.48K ﹤0.01% 543
2016
Q4 		$241K Buy
13,470
+400
+3% +$7.25K ﹤0.01% 539
2016
Q3 		$272K Sell
13,070
-26,980
-67% -$669K ﹤0.01% 506
2016
Q2 		$1.08M Buy
40,050
+540
+1% +$14.8K 0.02% 273
2016
Q1 		$1.07M Sell
39,510
-1,940
-5% -$52K 0.02% 267
2015
Q4 		$1.2M Sell
41,450
-300
-0.7% -$8.3K 0.02% 251
2015
Q3 		$1.13M Buy
41,750
+16,230
+64% +$460K 0.02% 257
2015
Q2 		$699K Sell
25,520
-11,950
-32% -$336K 0.01% 333
2015
Q1 		$1M Buy
37,470
+3,100
+9% +$71.4K 0.02% 299
2014
Q4 		$727K Buy
34,370
+2,850
+9% +$63.7K 0.01% 324
2014
Q3 		$750K Buy
31,520
+11,580
+58% +$266K 0.01% 314
2014
Q2 		$461K Sell
19,940
-880
-4% -$19.4K 0.01% 377
2014
Q1 		$475K Buy
20,820
+320
+2% +$6.82K 0.01% 378
2013
Q4 		$379K Sell
20,500
-140
-0.7% -$2.44K 0.01% 402
2013
Q3 		$349K Sell
20,640
-1,400
-6% -$23.5K 0.01% 403
2013
Q2 		$342K Buy
+22,040
New +$367K 0.01% 379

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Davenport & Co's NVO Position: Q2 2026 in Review

Davenport & Co reduced its Novo Nordisk (NVO) stake by 16% in Q2 2026, selling an estimated $575K and leaving 71,408 shares worth $3.42M. The position accounts for 0.02% of the portfolio, ranked #451.

Davenport & Co first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $147M in Q3 2025. 242 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Davenport & Co held 71,408 shares of Novo Nordisk worth $3.42M as of Q2 2026.
  • Davenport & Co sold 13,376 Novo Nordisk shares in Q2 2026, an estimated $575K.
  • Novo Nordisk made up 0.02% of Davenport & Co's portfolio in Q2 2026, its #451 holding.
  • Davenport & Co first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Novo Nordisk position peaked at $147M in Q3 2025.
  • 242 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.